Abstract
Background: The Coronavirus Disease 2019 (COVID-19) epidemic has been largely controlled in China, to the point where case fatality rate (CFR) data can be comprehensively evaluated. Methods: Data on confirmed patients, with a final outcome reported as of 29 March 2020, were obtained from official websites and other internet sources. The hospitalized CFR (HCFR) was estimated, epidemiological features described, and risk factors for a fatal outcome identified. Findings: The overall CFR in China was estimated to be 4.6% (95% CI 4.5%-4.8%). It increased with age and was higher in males than females. The highest CFR observed was in male patients ≥70 years old. Although the outcome of infection is generally worse for males, this adverse effect from male sex decreased as people get old. Differential age/sex CFR patterns across geographical regions were found: the age effect on CFR was greater in other provinces outside Hubei than in Wuhan. An effect of longer interval from symptom onset to admission was only observed outside Hubei, not in Wuhan. By performing multivariate analysis and survival analysis, the higher CFR was associated with older age, and male sex. Only in regions outside Hubei, longer interval from symptom onset to admission, were associated with higher CFR. Interpretation: This up-to-date and comprehensive picture of COVID-19 CFR and its drivers will help healthcare givers target limited medical resources to patients with high risk of fatality.
Introduction
Early in the COVID-19 pandemic, Case Fatality Rate (CFR) estimates varied significantly, often biased by incomplete data or the "lag-time" between infection and clinical outcome. Most early studies focused exclusively on the first few weeks in Wuhan, which did not necessarily reflect how the virus behaved as it spread to other provinces with different healthcare capacities. This study provides a "post-game" analysis of the first wave in China (up to March 29, 2020), comparing the epicenter (Wuhan/Hubei) with the rest of mainland China to disentangle biological risk factors from systemic ones like healthcare strain.
Methods and Data Sources
The researchers conducted a descriptive epidemiological analysis using a curated database of over 81,000 confirmed cases. Key methodological features included:
- Estimation of HCFR: Calculation of the Hospitalized Case Fatality Rate, focusing on patients with known final outcomes (death or recovery).
- Statistical Modeling: Univariate and multivariate logistic regression to identify independent risk factors for death.
- Survival Analysis: Competing risk models to estimate the cumulative incidence of death over time.
- Comparative Analysis: A direct comparison of 443 fatal cases from six Wuhan hospitals against 118 fatal cases from provinces outside Hubei.
Data was aggregated from official National Health Commission records, provincial health commissions, and augmented with clinical details scraped from news aggregators (e.g., BNO News) and online reports (e.g., 163.com). Peer-reviewed literature was used to validate the curated database.
Key Insights and Regional Dynamics
The "Admission Delay" Threshold
Outside Hubei, the interval from symptom onset to hospital admission was a critical predictor of mortality. Patients who waited more than 10 days to be admitted had nearly five times the odds of death compared to those admitted within five days. Interestingly, this correlation was not significant in Wuhan, likely because the overwhelmed healthcare system there created bottlenecks that neutralized the benefits of early care-seeking.
Demographic Risk Factors
While being male was a consistent risk factor, the relative risk compared to females decreased with age. Furthermore, the "age effect" was more pronounced outside Hubei. In regions with fewer cases, the elderly faced a disproportionately higher risk, possibly due to different clinical management strategies compared to the high-volume hospitals in Wuhan.
The Deception of "Mild" Cases
Approximately 39.6% of patients who eventually died were initially admitted with "mild" pneumonia. This underscores the deceptive nature of the disease’s progression and the necessity for vigilant monitoring even in seemingly stable patients.
Key Results
- Overall CFR: The national CFR was estimated at 4.6% (95% CI: 4.5%–4.8%).
- Age Dominance: Patients ≥ 70 years old outside Hubei faced a 167-fold increase in the risk of death compared to those under 50.
- Sex Disparities: The risk of death for males was significantly higher, with a Risk Ratio (RR) of 1.94 in Wuhan and 1.49 in other provinces.
- Clinical Course: The median time from symptom onset to death was 15 days, with roughly 32% of fatal cases occurring within the first 10 days of symptoms.
Limitations and Future Outlook
The study primarily included hospitalized patients, meaning the calculated CFR is likely higher than the true Infection Fatality Rate (IFR) which would include asymptomatic cases. Additionally, while the study describes clear demographic patterns, it does not investigate the underlying biological mechanisms, such as ACE2 expression or immunological differences. Future research should explore the specific immunological drivers of the "cytokine storm" and apply these regional modeling insights to other global contexts facing healthcare surges.
Summary updated